Aptose Biosciences's market cap is currently ―. The company's EPS TTM is $-7.75; its P/E ratio is -0.16; Aptose Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-1.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -11.96M	$ -11.45M	$ -14.13M	$ -13.68M	$ -10.00M
EBITDA	$ -11.85M	$ -11.45M	$ -14.02M	$ -13.54M	$ -9.90M
Net Income Common Stockholders	$ -11.96M	$ -11.45M	$ -14.13M	$ -13.68M	$ -10.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.25M	$ 17.72M	$ 23.31M	$ 35.72M	$ 46.96M
Total Assets	$ 12.99M	$ 20.88M	$ 26.57M	$ 39.33M	$ 51.03M
Total Debt	$ 1.01M	$ 1.11M	$ 1.20M	$ 1.22M	$ 1.30M
Net Debt	$ -8.24M	$ -16.61M	$ -22.10M	$ -34.50M	$ -45.66M
Total Liabilities	$ 15.89M	$ 13.10M	$ 12.79M	$ 13.34M	$ 13.29M
Stockholders Equity	$ -2.90M	$ 7.78M	$ 13.79M	$ 25.99M	$ 37.74M
Cash Flow	-
Free Cash Flow	$ -9.26M	-	$ -13.52M	$ -11.30M	$ -8.65M
Operating Cash Flow	$ -9.26M	-	$ -13.49M	$ -11.30M	$ -8.65M
Investing Cash Flow	$ 1.94M	-	$ -1.97M	$ -2.96M	$ 17.57M
Financing Cash Flow	$ 854.00K	-	$ 1.10M	$ 50.00K	$ 51.00K

Currency in USD

Aptose Biosciences Earnings and Revenue History

Income Statement >

Aptose Biosciences Debt to Assets

Balance Sheet >

Aptose Biosciences Cash Flow

Cash Flow >

Aptose Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing